Publications

    List of publications on Pubmed is available at the following link:

    https://www.ncbi.nlm.nih.gov/myncbi/18EG7EcTe-05A/bibliography/public/

    Total number of citations - 2233

    h index - 23

    i10 index - 60

    Journal Articles Published

    1. Parija SC, Misra DP. Evaluation of reverse passive hemagglutination (RPHA) test for the detection of antigen in serum for the diagnosis of cystic echinococcosis. J Parasit Dis December 2007, 31(2) : 155-158.

    2. Misra DP, Das S, Pattnaik M, Singh SC, Jena RK. Relationship of hepatic and renal dysfunction with haemorrhological parameters in Plasmodium falciparum malaria. J Assoc Physicians India. 2011; 59 : 552-6.

    3. Misra DP, Das S, Sahu PK. Prevalence of inflammatory markers (hsCRP, NF-?B and Adiponectin) In Indian subjects with Type 2 Diabetes Mellitus with and without macrovascular complications. MetabSyndrRelatDisord. 2012 Jun;10(3):209-13. doi: 10.1089/met.2011.0044.

    4. Kumar U, Gokhle SS, Sreenivas S, Kaur S, Misra DP. Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications. Rheumatol Int. 2013 Apr;33(4):1047-52. doi: 10.1007/s00296-012-2466-5.

    5. Das S, Misra DP, Sahu PK. Study of hsCRP, adiponectin, NF-?B in low bodyweight, standard bodyweight and obese subjects with type 2 diabetes mellitus in India. Journal of Diabetes Mellitus. 2012 Nov ; 2(4):386-92. doi: 10.4236/jdm.2012.24060.

    6. Misra DP *, Lawrence A, Agarwal V. Gangrene in Takayasu*s arteritis. Indian J Rheumatol. 2013;8:137-8. doi: 10.1016/j.injr.2013.06.001.

    7. Parida JR, Misra DP, Lawrence A. What is your diagnosis? Cryofibrinogenemia presenting as peripheral gangrene: A case report with review of literature. Indian J Rheumatol. 2014;9:34-6. doi: 10.1016/j.injr.2013.12.001

    8. Parida JR, Misra DP, Wakhlu A, Agarwal V. Antiphospholipid antibody syndrome. Clinical Queries : Nephrology. 2014; 3 (1), 9-14. doi: 10.1016/j.cqn.2014.03.007.

    9. Parida JR, Misra DP, Patro PS, Agarwal V. Prostatic calcification in ochronosis. Indian J Rheumatol. 2014;9(3):155-156. doi:10.1016/ j.injr.2014.02.007.

    10. Misra DP, Prasad N, Wakhlu A, Agarwal V. Pauciimmune vasculitis. Clinical Queries: Nephrology. 2014; 3(2):82-89. doi: 10.1016/j.cqn.2014.08.001.

    11. Bolia R, Misra DP *, Aggarwal A, Srivastava A. Pediatric selective IgM deficiency and IgG4 deficiency - an extremely unusual association. BMJ Case Rep. 2014 Sep 1;2014. pii: bcr2014204769. doi: 10.1136/bcr-2014-204769.

    12. Misra DP, Parida JR, Chowdhury AC, Agarwal V. Pulmonary co-infection with Nocardia and Aspergillus in a patient with Adult-onset Still*s Disease receiving steroids and tacrolimus. BMJ Case Rep. 2014; doi:10.1136/bcr-2014-207335.

    13. Misra DP *, Parida JR, Chowdhury AC, Pani KC, Kumari N, Krishnani N, Agarwal V. Lepra reaction with Lucio phenomenon mimicking cutaneous vasculitis. Case Rep Immunol. 2014.doi: 10.1155/2014/641989.

    14. Parida JR, Misra DP, Wakhlu A, Agarwal V. Is non-biological treatment of rheumatoid arthritis as good as biologics? World J Orthop. 2015;6(2):278-283. doi:10.5312/wjo.v6.i2.278.

    15. Misra DP *, Chowdhury AC, Parida JR, Jain SK, Agarwal V. Unusual co-existence of dural sinus thrombosis and aneurysmal subarachnoid hemorrhage in a patient with lupus. Lupus. 2015;24:994-997. doi: 10.1177/0961203315570687.

    16. Misra DP *, Sukesh E, Chowdhury AC, Agarwal V. Refractory polymyositis undergoing remission following anti-tubercular therapy. BMJ Case Rep 2015. doi:10.1136/bcr-2015-209291.

    17. Misra DP, Aggarwal A, Lawrence A, Agarwal V, Misra R. Pediatric-onset Takayasu*s arteritis: Clinical features and short-term outcome. Rheumatol Int. 2015;35(10):1701-6. doi: 10.1007/s00296-015-3272-7.

    18. Misra DP *, Parida JR, Chowdhury AC, Agarwal V. Rheumatoid hand. J Clin Rheumatol. 2015;21(4):228. doi:10.1097/RHU.0000000000000253.

    19. Chowdhury AC, Misra DP *, Patro PS, Agarwal V. Toxic epidermal necrolysis due to therapy with cyclophosphamide and mesna in a patient with seronegative rheumatoid arthritis with rheumatoid vasculitis. Z Rheumatol. 2016;75(2):200-2 doi: 10.1007/s00393-015-1632-z

    20. Shenoy SN, Misra DP, Chowdhury AC, Aggarwal A. An unusual case of hip pain in a child: Osteoid osteoma. Internet Journal of Rheumatology and Clinical Immunology. 2015;3(1):CS5. doi: 10.15305/ijrci/v3i1/143.

    21. Misra DP, Wakhlu A, Agarwal V. In the Treatment of Rheumatoid Arthritis, Old is The New Way Forward. Editorial. JK Science 2015;17(2): 57-9.

    22. Guleria A, Misra DP, Rawat A, Dubey D, Khetrapal CL, Bacon P, Misra R, Kumar D. NMR based serum metabolomics discriminates Takayasu Arteritis from Healthy Individuals: A proof of principle study. J Proteome Res. 2015 ;14(8):3372-81. doi: 10.1021/acs.jproteome.5b00422.

    23. Misra DP, Chowdhury AC, Phatak S, Agarwal V. Scleroderma: not an orphan disease anymore. World J Rheumatol. 2015;5(3):131-141. doi: 10.5499/wjr.v5.i3.131.

    24. Aggarwal A, Misra DP. Enthesitis-related arthritis. Clin Rheumatol. 2015;34(11):1839-46. doi:10.1007/s10067-015-3029-4.

    25. Parida JR, Misra DP *, Agarwal V. Urbach-Wiethe syndrome. BMJ Case Rep 2015. doi:10.1136/bcr-2015- 212443.

    26. Ajmani S, Misra DP *, Raja DC, Mohindra N, Agarwal V. Behcet*s Disease with Intracardiac Thrombus Presenting with Fever of Unknown Etiology. Case Rep Immunol 2015. doi:10.1155/2015/149359

    27. Misra DP, Misra R. Assessment of disease activity in Takayasu*s arteritis. Indian J Rheumatol. 2015;10:S43-47. doi: 10.1016/j.injr.2015.08.006.

    28. Misra DP *, Chowdhury AC, Lal H, Mohindra N, Agarwal V. Gangrene in Takayasu*s arteritis - a report of 2 cases and review of literature. Rheumatol Int. 2016 Mar;36(3):449-53. doi: 10.1007/s00296-015-3392-0.

    29. Ajmani S, Chowdhury AC, Misra DP *, Agarwal V. Behcet*s disease without oral ulcers presenting with erythema nodosum and deep venous thrombosis. Trop Doct. 2016; 46(1): 34-36. doi: 10.1177/0049475515595169.

    30. Misra DP *, Agarwal V. Innate immune cells in the pathogenesis of primary systemic vasculitis. Rheumatol Int. 2016;36:169-182. doi:10.1007/s00296-015-3367-1.

    31. Misra DP *, Jain VK, Negi VS. Splenectomy increases the subsequent risk of systemic lupus erythematosus - a word of caution. Rheumatol Int. 2016; 36:277-278. doi: 10.1007/s00296-015-3406-y.

    32. Misra DP, Chowdhury AC, Sukesh E, Aggarwal A, Kumar S, Agarwal V. Endocarditis: the great mimic of rheumatic diseases. Trop Doct 2016; 46(4): 180-86.

    33. Misra DP *, Shenoy SN. Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int. 2017; 37(1):151-167. doi: 10.1007/s00296-016-3435-1.

    34. Misra DP, Chaurasia S, Misra R. Increased circulating Th17 cells, serum IL-17A and IL-23 in Takayasu arteritis. Autoimmune Dis. 2016. doi: 10.1155/2016/7841718.

    35. Misra DP *, Negi VS. Topical review - Takayasu*s arteritis. Indian J Rheumatol 2016; 2:73-77. doi: 10.1016/j.injr.2016.04.001.

    36. Misra DP *, Agarwal V, Negi VS. Rheumatology in India : A Bird*s Eye View on Organization, Epidemiology, Training Programs and Publications. J Korean Med Sci. 2016 Jul;31(7):1013-1019. doi:10.3346/jkms.2016.31.7.1013.

    37. Sukesh E, Chowdhury AC, Phatak S, Misra DP, Verma R, Lawrence A. Multiple myeloma masquerading as severe seropositive rheumatoid arthritis with subcutaneous nodules and mononeuritis multiplex. Int J Rheum Dis Int J Rheum Dis. 2017 Sep;20(9):1297-1302.

    38. Misra DP *, Chengappa KG, Jain VK, Negi VS. Talonavicular and naviculocuneiform joint involvement in diffuse idiopathic skeletal hyperostosis. J Clin Rheumatol. 2017; 23(2):119.

    39. Misra DP *, Chengappa KG, Mahadevan A, Jain VK, Negi VS. Sarcoidosis, Neurotoxoplasmosis& Golimumab Therapy. QJM 2016 Dec;109(12):817-818. doi: 10.1093/qjmed/hcw197.

    40. Mariaselvam CM, Tamouza R, Krishnamoorthy R, Charron D, Misra DP, Jain VK, Negi VS. Association of NKG2D gene variants with susceptibility and severity of Rheumatoid Arthritis. Clin Exp Immunol. 2017; 187(3):369-375. doi: 10.1111/cei.12891.

    41. Misra DP *, Agarwal V, Negi VS. Comment on: Emerging evidence base therapies for systemic sclerosis. Indian J Rheumatol 2016;11:238-9. doi: 10.4103/0973-3698.192679.

    42. Misra DP *, Usdadiya JB, Negi VS. Nonbiologic Disease-modifying Antirheumatic Drugs in Pregnancy. Indian J Rheumatol 2016; 11: 156-62.

    43. Ravindran V, Misra DP *, Negi VS. Letter to the Editor: Predatory Practices and How to Circumvent Them: a Viewpoint from India. J Korean Med Sci 2017; 32: 160-161. doi: 10.3346/jkms.2017.32.1.160.

    44. Misra DP *, Krishnan N, Gocchait D, Emmanuel D, Negi VS. Takayasu arteritis (TA) first presenting with intestinal ischemia: a case report and review of gastrointestinal tract involvement (ischemic and non-ischemic) associated with TA. Rheumatol Int 2017; 37(1):169-175. doi: 10.1007/s00296-016-3600-6.

    45. Misra DP, Sharma A, Kadhiravan T, Negi VS. A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis. Autoimmun Rev. 2017 Feb;16(2):179-191. doi: 10.1016/j.autrev.2016.12.009.

    46. Jain A, Misra DP *, Jain VK, Negi VS. Spontaneous Pneumomediastinum in Dermatomyositis. Indian J Rheumatol 2017;12:54-5.

    47. Jain A, Misra DP *, Ramesh A, Basu D, Jain VK, Negi VS. Tuberculosis mimicking primary systemic vasculitis: not to be missed! Tropical Doctor 2017; 47(2):158-164.

    48. Parchand SM, Vijitha VS, Misra DP. Combined Central Retinal Artery and Vein Occlusion in Lupus. BMJ Case Rep. 2017. doi:10.1136/bcr-2016-218848

    49. Negi VS, Panneer D, Misra DP, Jain VK, Usdadiya JB, Antony PT, Gulati R. Mannose Binding Lectin (MBL) codon 54 (rs1800450) polymorphism predisposes towards medium vessel vasculitis in patients with Systemic Lupus Erythematosus. Clin Rheumatol. 2017 Apr;36(4):837-843. doi: 10.1007/s10067-017-3539-3.

    50. Negi VS, Mariaselvam CM, Misra DP, Muralidharan N, Fortier C, Charron D, Krishnamoorthy R, Tamouza R. Polymorphisms in the promoter region of iNOS predispose to rheumatoid arthritis in south Indian Tamils. Int J Immunogenet. 2017 Jun;44(3):114-121. doi: 10.1111/iji.12315.

    51. Misra DP *, Agarwal V, Sharma A, et al 2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries? Ann Rheum Dis. 2017 Nov;76(11):e47. doi: 10.1136/annrheumdis-2017-211446.

    52. Muralidharan N, Misra DP, Jain VK, Negi VS. Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis. Clin Rheumatol. 2017 Jun;36(6):1253-1259. doi: 10.1007/s10067-017-3608-7.

    53. Misra DP *, Negi VS. Interferon targeted therapies in systemic lupus erythematosus. Mediterr J Rheumatol. 2017;28(1):23-29.

    54. Zanwar A, Ahmed S, Misra DP *, Agarwal V, Sharma A, Wakhlu A, et al. Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Indian J Rheumatol2017;12:104-9.

    55. Misra DP *, Agarwal V. Outcome assessment in rheumatoid arthritis: The patient says the best. Indian J Rheumatol2017;12:68-9.

    56. Wakhlu A, Chowdhury AC, Mohindra N, Tripathy SR, Misra DP, Agarwal V. Assessment of extent of skin involvement in scleroderma using shear wave elastography. Indian J Rheumatol2017;12:194-8.

    57. Misra DP *, Wakhlu A, Agarwal V, Sharma A, Negi VS. Letter to the Editor: Appropriate Statistical Analysis and Research Reporting.J Korean Med Sci. 2017; 32(8):1379-1380.

    58. Mariaselvam CM, Boukouaci W, Charron D, Krishnamoorthy R, Tamouza R, Misra DP, Negi VS. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population. Int J Rheum Dis. 2018 Mar;21(3):656-663.

    59. Ravindran V, Misra DP *, Negi VS. Challenges facing a Rheumatology journal: Role and credentials of editorial board members. Mediterr J Rheumatol 2017; 28(2):51-52

    60. Muralidharan N, Gulati R, Misra DP, Negi VS. Nonassociation of homocysteine gene polymorphisms with treatment outcome in South Indian Tamil Rheumatoid Arthritis patients. Clin Exp Med. 2018 Feb;18(1):101-107.

    61. Naidu GSRSNK, Misra DP, Sharma A. Current and Future Treatment Options for Takayasu Arteritis and Persistent Therapeutic Challenges. Current Treatment Options in Rheumatology 2017;3(3):141-152

    62. Ravindran V, Misra DP, Negi VS. Publishing or perishing: For the Best; for the Worst!. Indian J Rheumatol2017;12:126-7.

    63. Misra DP *, Ravindran V, Wakhlu A, Sharma A, Agarwal V, Negi VS. Plagiarism: a Viewpoint form India. J Korean Med Sci. 2017 Nov;32(11):1734-1735. doi: 10.3346/jkms.2017.32.11.1734.

    64. Devaraju P, Gulati R, Misra DP, Negi VS. The Protein Tyrosine Phosphatase, Nonreceptor Type 22-1858C->T 23 (rs2476601) Polymorphism is not a Genetic Risk Factor for Systemic Lupus Erythematosus in Indian Tamils. Indian J Rheumatol 2017;12:214-8. doi: 10.4103/injr.injr_90_17.

    65. Misra DP *, Ravindran V, Wakhlu A, Sharma A, Agarwal V, Negi VS. Publishing in black and white: the relevance of listing of scientific journals. Rheumatol Int. 2017;37(11):1773-1778. doi: 10.1007/s00296-017-3830-2.

    66. Misra DP, Ravindran V, Agarwal V. Plagiarism: Software-based detection and the importance of (Human) hardware. Indian J Rheumatol 2017;12:188-9.

    67. Jain A, Misra DP *, Sharma A, Wakhlu A, Agarwal V, Negi VS. Vasculitis and vasculitis-like manifestations in monogenic autoinflammatory syndromes. Rheumatol Int. 2018;38:13-24. doi: 10.1007/s00296-017-3839-6.

    68. Devaraju P, Mehra S, Gulati R, Antony PT, Jain VK, Misra DP, Negi VS. The IRF5 rs2004640 (G/T) polymorphism is not a genetic risk factor for SLE in a South Indian ethnic population. Indian J Med Res 2018 Jun;147(6):560-566.

    69. Wakhlu A, Misra DP, Agarwal V. Scleroderma and related disorders. Indian J Rheumatol 2017;12:S141.

    70. Phatak S, Ajmani S, Agarwal V, Misra DP *. Phosphodiesterase-5 inhibitors: Raynaud*s and beyond. Indian J Rheumatol 2017;12:S227-31.

    71. Misra DP *. Autoinflammation in rheumatic and musculoskeletal disorders. Rheumatol Int. 2018;38:1-2. doi: 10.1007/s00296-017-3921-0.

    72. Misra DP *, Ravindran V, Wakhlu A, Sharma A, Agarwal V, Negi VS. Better understanding of publishing practices and indexing of target journals is essential. Rheumatol Int. 2018;38(2):317-318. doi: 10.1007/s00296-017-3897-9.

    73. Misra DP *, Agarwal V. Systematic reviews: challenges for their justification, related comprehensive searches, and implications. J Korean Med Sci. 2018;33(12):e92

    74. Wakhlu A, Sahoo RR, Rai MK, Parida JR, Misra DP, Agarwal V. Serum Interleukin-6, Interleukin-17 and Transforming Growth Factor beta levels in Systemic Sclerosis and Correlation with Clinical Manifestations. Indian J Rheumatol 2018;13:107-12.

    75. Gupta L, Ahmed S, Choudhury GD, Misra DP, Agarwal V. Poor Quality of Life in Indian Ankylosing Spondylitis Patients. Indian J Rheumatol 2018;13:101-6.

    76. Misra DP *, Agarwal V. Comment on: A comparison of 3 rheumatoid arthritis disease activity indices in routine clinical practice. Indian J Rheumatol 2018;13:75.

    77. Kashyap S, Kumar S, Agarwal V, Misra DP, Phadke SR, Kapoor A. Gene expression profiling for coronary artery disease and its relation with different severity. Journal of Genetics 2018. J Genet. 2018 Sep;97(4):853-867.

    78. Kashyap S, Kumar S, Agarwal V, Misra DP, Rai¬¬ MK, KapoorA. The association of polymorphic variants, rs2267788, rs1333049 and rs2383207 with coronary artery disease, its severity and presentation in North Indian population. Gene 2018;648:89-96

    79. Gupta V, Misra DP, Mohindra N, Kumari N, Agarwal V. Sternoclavicular joint arthritis as the initial presentation of sarcoidosis. Eur J Rheumatol. 2018; 5(2): 142-144.

    80. Misra DP *, Sharma A, Agarwal V. Guidelines for management of rheumatic diseases in developing countries from basics to real-world situation: relevance, need, and processes for development. Rheumatol Int. 2018;38:549-556.

    81. Mehra S, Usdadiya JB, Jain VK, Misra DP, Negi VS. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study. Rheumatol Int. 2018:38:557-568. doi: 10.1007/s00296-018-3995-3.

    82. Misra DP *, Sharma A, Agarwal V. Cardiovascular disease in ANCA-associated vasculitis: the danger lurking beneath the surface! Semin Arthritis Rheum. 2018 Oct;48(2):e21-e22

    83. Misra DP, Pani KC, Shenoy SN, Wakhlu A, Ghosh P, Hissaria P, Agarwal V. Enhancement of knowledge and skills in laboratory techniques for autoantibody evaluation among young rheumatologists during a single-day hands-on workshop. Indian J Rheumatol 2018;13:178-81.

    84. Misra DP *, Agarwal V. Rheumatology Training in India: Pragmatism Needed to Adapt to the Needs of the Burgeoning Population. Indian J Rheumatol 2018;13:80-1.

    85. Ajmani S, Misra DP, Lawrence A. SLE presenting as migratory arthritis, chorea and nephritis. Mediterr J Rheumatol. 2018;29(1):43-45

    86. Goyal M, Misra DP *, Rajadhyaksha S, Singh YP, Goyal N, Ravindran V. Effectiveness of a 1-day workshop on scientific writing conducted by the Indian Journal of Rheumatology. Indian J Rheumatol2018;13:117-20.

    87. Misra DP *, Wakhlu A, Agarwal V. Letter to the Editor: Individual Researcher and Author Metrics: a Viewpoint from India. J Korean Med Sci. 2018 Jul 9;33(28):e202

    88. Kashyap S, Kumar S, Agarwal V, Misra DP, Phadke SR, Kapoor A. Protein protein interaction network analysis of differentially expressed genes to understand involved biological processes in coronary artery disease and its different severity. Gene Reports 2018;12:50-60

    89. Wakhlu A, Misra DP *.Handbook on research methodology. Indian J Rheumatol2018;13:145.

    90. Seth G, Chengappa KG, Misra DP, Babu R, Belani P, Shanoj KC, Kumar G, Negi VS. Lupus retinopathy: a marker of active systemic lupus erythematosus. Rheumatol Int. 2018 ;38(8):1495-1501.

    91. Zanwar A, Jain A, Gupta L, Chaurasia S, Kumar S, Misra DP, Misra R. Serum BAFF and APRIL levels in Indian patients with Takayasu arteritis. Clin Rheumatol. 2018 Dec;37(12):3439-3442. doi: 10.1007/s10067-018-4207-y.

    92. Arthritis in Sarcoidosis Group (ASG), Agarwal V, Agrawal V, Aggarwal A, Aggarwal P, Chowdhury AC, Ghosh P, Jain A, Lawrence A, Misra DP, Misra R, Mohapatra MM, Nath A, Negi VS, Pandya S, Reddy VV, Prasad S, Sharma A, Shobha V, Singh YP, Tripathy SR, Wakhlu A. Arthritis in sarcoidosis from India: A multicentric study. Int J Rheum Dis 2018 2018 Sep;21(9):1728-1733.

    93. Misra DP *, Sharma A, Agarwal V. Rheumatology science and practice in India. RheumatolInt 2018; 38:1587-1600.

    94. Michael BNR, Misra DP, Chengappa KG, Negi VS. Relevance of elevated microparticles in peripheral blood and synovial fluid of patients with Rheumatoid Arthritis. Indian J Rheumatol2018;13:222-8.

    95. Misra DP, Naidu GSRSNK, Agarwal V, Sharma A. Vasculitis research: Current trends and future perspectives. Int J Rheum Dis. 2019;22:10-20. doi: 10.1111/1756-185X.13370.

    96. Misra DP *, Agarwal V. CANTOS - is selective targeting of inflammation in atherosclerosis enough?J R Coll Physicians Edinb 2018; 48: 246-247

    97. Jain A, Kumar D, Guleria A, Misra DP, Zanwar A, Chaurasia S, Kumar S, Kumar U, Mishra SK, Goel R, Danda D, Misra R. NMR-based Serum Metabolomics of patients with Takayasu arteritis (TA) - Relationship with disease activity. J Proteome Res. 2018;17(9):3317-3324.

    98. Chaturvedi S, Misra DP, Prasad N, Rastogi K, Singh H, Rai M, Agarwal V. 5-HT2 and 5-HT2B antagonists attenuate pro-fibrotic phenotype in human adult dermal fibroblasts by blocking TGF-ß1 induced non-canonical signaling pathways including STAT3: implications for fibrotic diseases like scleroderma. Int J Rheum Dis. 2018;21:2128-2138.

    99. Naidu GSRSNK, Misra DP, Rathi M, Sharma A. Is Granulomatosis with polyangiitis in Asia different from the west? Int J Rheum Dis. 2019;22:90-94.

    100. Misra DP *, Ravindran V, Agarwal V. Integrity of Authorship and Peer Review Practices: Challenges and Opportunities for Improvement. J Korean Med Sci. 2018 Nov 12;33(46):e287

    101. Emmanuel D, Parija SC, Jain A, Misra DP, Kar R, Negi VS. Persistent eosinophilia in rheumatoid arthritis: a prospective observational study. Rheumatol Int 2019;39:245-53

    102. Ajmani S, Singh H, Chaturvedi C, Mishra R, Rai MK, Jain A, Misra DP, Agarwal V. Utility of neutrophil CD64 and serum TREM-1 in distinguishing bacterial infection from disease flare in SLE and ANCA-associated vasculitis. Clin Rheumatol. 2019 Apr;38(4):997-1005.

    103. Mistry RR, Patro P, Agarwal V, Misra DP *. Enthesitis-related arthritis: current perspectives. Open Access Rheumatol2019;11:19-31

    104. Patro P, Agarwal V, Misra DP *. Comment on: A novel glucocorticoid-free maintenance regimen for AAV. Rheumatology (Oxford). 2019 Jun 1;58(6):1117-1119.

    105. Misra DP *, Agarwal V. Real-world evidence in rheumatic diseases: relevance and lessons learnt. Rheumatol Int 2019;39:403-16

    106. Misra DP, Wakhlu A, Agarwal V, Danda D. Recent advances in the management of Takayasu Arteritis. Int J Rheum Dis 2019; 22: 60-68.

    107. Zanwar A, Gupta L, Misra DP, Agarwal V. Approach to non-compressive backpain. Neurol India 2019;67:671-8.

    108. Misra DP *, Wakhlu A. Challenges in assessing the disease activity of Takayasu arteritis. Indian J Rheumatol 2019;14:3-4.

    109. Misra DP, Ravindran V. Peer review in academic publishing: threats and challenges. J R Coll Physicians Edinb 2019 Jun;49(2):99-100.

    110. Ahmed S, Misra DP, Agarwal V. Interleukin-17 pathways in systemic sclerosis-associated fibrosis. Rheumatol Int 2019; 39:1135-1143. https://doi.org/10.1007/s00296-019-04317-5

    111. Misra DP, Ravindran V, Sharma A, Wakhlu A, Negi VS, Chaturvedi S, Agarwal V. Physicians perception of Rheumatology practice and training in India. J Assoc Physicians India 2019; 67: 38-43

    112. Singh H, Agarwal V, Chaturvedi V, Misra DP, Jaiswal AK, Prasad N. Reciprocal relationship between HDAC2 and P-glycoprotein/MRP-1 and their role in steroid resistance in childhood Nephrotic syndrome. Front. Pharmacol. 2019;10:558. doi: 10.3389/fphar.2019.00558

    113. Misra DP *, Wakhlu A, Sharma A, Negi VS, Agarwal V, Chaturvedi V. Comment on: 2018 APLAR axial spondyloarthritis treatment recommendations - need for greater cognizance of regional needs? Int J Rheum Dis 2019;22:1340-1341.

    114. Nath A, Hashim Z, Khan A, Gupta M, Neyaz Z, Misra DP, Mishra R, Srivastava R. Experience of sarcoidosis and factors predicting relapse at a tertiary care institute in North India. Indian J Rheumatol 2019;14:265-70.

    115. Misra DP *, Agarwal V. Fostering collaboration between journals: Growing together for a better future for science. Indian J Rheumatol 2019;14:94-5.

    116. Misra DP, Ravindran V. Conflicts of interest in academic publishing: when in doubt, declare!. J R Coll Physicians Edinb. 2019 Sep;49(3):179-181.

    117. Misra DP *, Agarwal V. Open Access Publishing in India: Coverage, Relevance, and Future Perspectives. J Korean Med Sci. 2019 Jul 15;34(27):e180. doi: 10.3346/jkms.2019.34.e180.

    118. Misra DP, Agarwal V. Challenges in rheumatology practice in Asia and Africa - shared concerns, common solutions? Afr J Rheumatol 2019; Vol 7(2): 39-40

    119. Misra DP, Naidu GSRSNK, Sharma A. Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis. Indian J Rheumatol 2019;14:218-28.

    120. Misra DP*, Agarwal V. Generating working hypotheses for original research studies. Cent Asian J Med Hypotheses Ethics 2020;1(1):14-19. https://doi.org/10.47316/cajmhe.2020.1.1.02

    121. Singh H, Prasad N, Misra DP, Jaiswal AK, Agarwal V. P-glycoprotein and/or histone deacetylase 2 regulates steroid responsiveness in childhood Nephrotic syndrome. Indian J Rheumatol 2020, 15(1):5-10

    122. Misra DP, Ravindran V. Reporting standards in scientific publishing: need, relevance and future perspectives. J R Coll Physicians Edinb 2019; 49: 269-71

    123. Muhammed H, Gupta L, Zanwar AA, Misra DP, Lawrence A, Agarwal V, Aggarwal A, Misra R. Infections Are Leading Cause of In-Hospital Mortality in Indian Patients With Inflammatory Myopathy. J Clin Rheumatol. 2021 27(3):114-119 doi: 10.1097/RHU.0000000000001214.

    124. Wakhlu A, Sahoo RR, Misra DP. Drug-induced rheumatic syndromes. Indian J Rheumatol 2019;14:S1-2.

    125. Misra DP, Patro P, Sharma A. Drug-induced vasculitis. Indian J Rheumatol 2019;14:S3-9.

    126. Harikrishnan G, Jain N, Verma V, Agarwal V, Misra DP *. IgA vasculitis with large vessel involvement. Rheumatology (Oxford). 2020 Jul 1;59(7):1790-1791. doi: 10.1093/rheumatology/kez603.

    127. Misra DP *, Agarwal V, Sharma A. Comment on: Derivation of an angiographically based classification system in Takayasu*s arteritis. Rheumatology (Oxford). 2020 May 1;59(5):1183-1184. doi: 10.1093/rheumatology/kez661.

    128. Kumar U, Jain A, Guleria A, R VK, Misra DP, Goel R, Danda D, Misra R, Kumar D. Circulatory Glutamine/Glucose ratio for evaluating disease activity in Takayasu arteritis: A NMR based serum metabolomics study. J Pharm Biomed Anal. 2020 Feb 20;180:113080. doi: 10.1016/j.jpba.2019.113080.

    129. Thomas KN, Ganguly S, Misra DP, Misra R, Gupta L. Thionamide-Induced Myositis: Report of a Case and Systematic Review of Literature. J Clin Rheumatol. 2020 Jan 15;. doi: 10.1097/RHU.0000000000001282. [Epub ahead of print]

    130. Misra DP *, Ahmed S, Agarwal V. Is biological therapy in systemic sclerosis the answer?. Rheumatol Int. 2020 May;40(5):679-694. doi: 10.1007/s00296-020-04515-6.

    131. Misra DP *, Agarwal V. Integrity of clinical research conduct, reporting, publishing and post-publication promotion in Rheumatology. Clin Rheumatol. 2020 Apr;39(4):1049-1060.

    132. Misra DP *, Ravindran V, Sharma A, Wakhlu A, Ahmed S, Negi VS, Agarwal V. Letter to the Editor: An Indian Perspective on Universal Open Access Publishing: Think of the Fire before Venturing Out of the Frying Pan!. J Korean Med Sci. 2020 Mar 2;35(8):e85. doi: 10.3346/jkms.2020.35.e85.

    133. Gupta L, Misra DP, Ahmed S, Jain A, Zanwar A, Lawrence A, Agarwal V, Aggarwal A, Misra R. Poor obstetric outcomes in Indian women with Takayasu arteritis. Adv Rheumatol. 2020 Mar 12;60(1):17.

    134. Misra DP *, Jain N, Harikrishnan G, Agarwal V. Multiple jeopardy: Diagnostic and therapeutic challenges in vasculitic flare. Int J Rheum Dis. 2020 Apr 7;. doi: 10.1111/1756-185X.13836.

    135. Misra DP *, Agarwal V. To act…….or to wait for the evidence: Ethics in the time of Covid-19! Indian J Rheumatol 2020;15:3-4.

    136. Misra DP, Ravindran V. Copyright and its violation : plagiarism and other publication misconducts - tread carefully to avoid falling! J R Coll Physicians Edinb 2020; 50: 3-5 | doi: 10.4997/JRCPE.2020.101

    137. Pradhan S, Das A, Singh H, Chaturvedi S, Singh K, Mishra R, Misra DP, Agarwal V. Steroid Responsiveness in Duchenne Muscular Dystrophy - Predictive Value of Epigenetic Regulator Histone Deacetylase 2. Indian J Pediatr. 2020 Sep;87(9):692-698. doi: 10.1007/s12098-020-03183-5.

    138. Misra DP *, Agarwal V, Gasparyan AY, Zimba O. Rheumatologists* perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. 2020 Jul;39(7):2055-2062. doi: 10.1007/s10067-020-05073-9.

    139. Shah S, Das S, Jain A, Misra DP, Negi VS. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Int J Rheum Dis. 2020 Apr 13;. doi: 10.1111/1756-185X.13842.

    140. Muralidharan N, Sundaram R, Kodidela S, Chengappa KG, Mariaselvam CM, Misra DP, Negi VS. Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients. Pharmacogenomics J. 2020 Apr;20(2):342-349. doi: 10.1038/s41397-019-0097-x.

    141. Misra DP *, Ravindran V, Sharma A, Wakhlu A, Negi VS, Chaturvedi V, Agarwal V. Rheumatology practice and training in India - a perspective from Rheumatology consultants. Indian J Rheumatol 2020;15:92-9.

    142. Gupta L, Misra DP, Agarwal V, Balan S, Agarwal V. Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India. Ann Rheum Dis. 2021 ;80(1):e1. doi: 10.1136/annrheumdis-2020-217509.

    143. Misra DP, Ravindran V. Publication models in scientific publishing-to open or not? J R Coll Physicians Edinb 2020; 50: 112-3

    144. Gasparyan AY, Misra DP, Yessirkepov M, Zimba O. Perspectives of immune therapy in coronavirus disease 2019 (COVID-19). 2020 May 11;35(18):e176. doi: 10.3346/jkms.2020.35.e176.

    145. Sharma S, Pande G, Rai MK, Misra DP, Gupta L, Agarwal V. The convergence of fibrosis and immune pathways: 5-HT2 and 5-HT2B antagonists attenuate profibrotic phenotype in human pancreatic stellate cells by modulating signal transducer and activator of transcription 3 phosphorylation. Indian J Rheumatol 2020. [Epub ahead of print]

    146. Kharbanda R, Naveen R, Misra DP, Agarwal V, Gupta L. Combined case record forms for collating obstetric outcomes in rare rheumatic diseases. Indian J Rheumatol 2020;15:191-3

    147. Chaturvedi S, Rai MK, Singh H, Misra DP, Prasad N, Agrawal V, et al. Dual inhibition by phosphodiesterase 5 and 5-HT2B Inhibitor leads to near complete amelioration of fibrotic potential of human adult dermal fibroblasts isolated from a scleroderma patient. Indian J Rheumatol 2021;16:43-8.

    148. Agarwal V, Gupta L, Davalbhakta S, Misra DP, Agarwal V, Goel A. Prevalent fears and inadequate understanding of Covid-19 among medical undergraduates in India: Results of a web-based survey. J R Coll Physicians Edinb. 2020 Sep;50(3):343-350. doi: 10.4997/JRCPE.2020.331.

    149. Goyal M, Patil P, Pathak H, Santhanam S, Goel A, Sharma V, Pandey A, Gupta N, Jain R, Akerkar S, Das P, Dudam R, Mendiratta N, Pandey BD, Cb M, Singh BK, Kumar S, Nolkha N, Jain S, Jain S, Sharma A, Misra DP. Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India. Ann Rheum Dis. 2020 Jul 15;. doi: 10.1136/annrheumdis-2020-218013. [Epub ahead of print]

    150. Gasparyan AY, Zimba O, Misra DP, Kitas GD. Monitoring Information Flow on Coronavirus Disease 2019 (COVID-19). Mediterr J Rheumatol. 2020 Sep;31(Suppl 2):243-246.

    151. Agarwal V, Sharma S, Gupta L, Misra DP, Davalbhakta S, Agarwal V, Aggarwal S. (2020). COVID-19 And Psychological Disaster Preparedness - An Unmet Need. Disaster Medicine and Public Health Preparedness 2020; Jun;14(3):387-390. doi:10.1017/dmp.2020.219

    152. Gupta L, Gasparyan AY, Misra DP, Agarwal V, Zimba O, Yessirkepov M. Information and Misinformation on COVID-19: a Cross-Sectional Survey Study. J Korean Med Sci. 2020 Jul 13;35(27):e256. doi: 10.3346/jkms.2020.35.e256.

    153. Jain A, Singh H, Nath A, Chaturvedi S, Ajmani S, Misra DP, Agarwal V. Distinct T-cell immunophenotypic signature in a subset of sarcoidosis patients with arthritis. J R Coll Physicians Edinb. 2020 Sep;50(3):226-232. doi: 10.4997/JRCPE.2020.304.

    154. Misra DP *, Agarwal V. Blaming the peer reviewer: don*t shoot the messenger. Indian J Rheumatol 2020;15:162-4.

    155. Goyal M, Dua A, Kedia A, Misra DP, Santhanam S, Ravindran V. Usefulness of a workshop on scientific writing and publication in improving the baseline knowledge deficit among postgraduates. J R Coll Physicians Edinb. 2020 Sep;50(3):316-321. doi: 10.4997/JRCPE.2020.323.

    156. Misra DP *, Patro P, Agarwal V. Biosimilars for vasculitis: promise requires validation by quality studies. Clin Rheumatol 2020 Oct;39(10):3149-3151.

    157. Viswanathan V, Jamthikar AD, Gupta D, Puvvula A, Khanna NN, Saba L, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Sharma A, Kancharana P, Misra DP, Agarwal V, Kitas GD, Nicolaides A, Suri JS. Does the Carotid Bulb Offer a Better 10-Year CVD/Stroke Risk Assessment Compared to the Common Carotid Artery? A 1516 Ultrasound Scan Study. Angiology. 2020 Nov;71(10):920-933. doi: 10.1177/0003319720941730.

    158. Davalbhakta S, Advani S, Kumar S, Agarwal V, Bhoyar S, Fedirko E, Misra DP, Goel A, Gupta L, Agarwal V. A systematic review of the smartphone applications available for coronavirus disease 2019 (COVID19) and their assessment using the mobile app rating scale (MARS). Journal of Medical Systems 2020;44:164

    159. Hazarika K, Gupta L, Dixit J, Sahoo RR, Misra DP, Wakhlu A. Aortitis in systemic lupus erythematosus: A report of two cases and review of literature. Indian J Rheumatol 2021;16:99-104.

    160. Skandha SS, Gupta SK, Saba L, Koppula VK, Johri AM, Khanna NN, Mavrogeni S, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Misra DP, Agarwal V, Sharma AM, Viswanathan V, Rathore VS, Turk M, Kolluri R, Viskovic K, Cuadrado-Godia E, Kitas GD, Nicolaides A, Suri JS. 3-D optimized classification and characterization artificial intelligence paradigm for cardiovascular/stroke risk stratification using carotid ultrasound-based delineated plaque: Atheromatic™ 2.0. ComputBiol Med. 2020 Aug 16;125:103958. doi: 10.1016/j.compbiomed.2020.103958. [Epub ahead of print]

    161. Suri JS, Puvvula A, Biswas M, Majhail M, Saba L, Faa G, Singh IM, Oberleitner R, Turk M, Chadha PS, Johri AM, Sanches JM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Ahluwalia P, Kolluri R, Teji J, Maini MA, Agbakoba A, Dhanjil SK, Sockalingam M, Saxena A, Nicolaides A, Sharma A, Rathore V, Ajuluchukwu JNA, Fatemi M, Alizad A, Viswanathan V, Krishnan PR, Naidu S. COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review. ComputBiol Med. 2020 Sep;124:103960. doi: 10.016/j.compbiomed.2020.103960.

    162. Sharma A, Naidu G, Sharma V, Jha S, Dhooria A, Dhir V, Bhatia P, Sharma V, Bhattad S, Chengappa, Gupta V, Misra DP, Chavan PP, Malaviya S, Dudam R, Sharma B, Kumar S, Bhojwani R, Gupta P, Agarwal V, Sharma K, Singhal M, Rathi M, Nada R, Minz RW, Chaturvedi V, Aggarwal A, Handa R, Grossi A, Gattorno M, Huang Z, Wang J, Jois R, Negi VS, Khubchandani R, Jain S, Arostegui JI, Chambers EP, Hershfield MS, Aksentijevich I, Zhou Q, Lee PY. Deficiency of adenosine deaminase 2 (DADA2) in Adults and Children: Experience from India. Arthritis Rheumatol. 2021 Feb;73(2):276-285.;. doi: 10.1002/art.41500.

    163. Misra DP *, Agarwal V. The perennial search for alternatives to corticosteroids in Rheumatology: is there light at the end of the tunnel? Clin Rheumatol 2020 Oct;39(10):2845-2848. doi: 10.1007/s10067-020-05357-0.

    164. Misra DP *, Gasparyan AY, Zimba O. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatol Int. 2020 Nov;40(11):1741-1751. doi: 10.1007/s00296-020-04694-2.

    165. Gupta L, Muhammad H, Naveen R, Kharbanda R, Harikrishnan G, Misra DP, Lilleker JB, Chinoy H, Agarwal V. Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians. Rheumatol Int. 2020 Dec;40(12):2047-2055. doi: 10.1007/s00296-020-04695-1.

    166. Misra DP, Ravindran V. Current perspectives on predatory or low-quality journals. J R Coll Physicians Edinb. 2020 Sep;50(3):224-225. doi: 10.4997/JRCPE.2020.303.

    167. Pattanaik SS, Muhammed H, Chatterjee R, Naveen R, Lawrence A, Agarwal V, Misra DP, Gupta L, Misra R, Aggarwal A. In-hospital mortality and its predictors in a cohort of SLE from Northern India. Lupus. 2020 Dec;29(14):1971-1977. doi: 10.1177/0961203320961474.

    168. Davalbhakta S, Sharma S, Gupta S, Agarwal V, Pandey G, Misra DP, Naik BN, Goel A, Gupta L, Agarwal V. Private Health Sector in India-Ready and willing, yet underutilized in the Covid-19 pandemic: A cross-sectional study.Front Public Health. 2020;8:571419. doi: 10.3389/fpubh.2020.571419

    169. Gupta L, Gasparyan AY, Zimba O, Misra DP *. Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists. Rheumatol Int. 2020 Dec;40(12):2023-2030.

    170. Kharbanda R, Naveen R, Misra DP, Gupta L, Agarwal V. Poor maternal and foetal outcomes in women with systemic sclerosis: an interview-based study at a tertiary centre. Rheumatol Int. 2021 Jun;41(6):1133-1142.;. doi: 10.1007/s00296-021-04793-8.

    171. Naveen R, Jain A, Muhammed H, Gupta L, Misra DP, Lawrence A, Agarwal V, Misra R, Aggarwal A. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities. Rheumatol Int. 2021 Mar;41(3):625-631. doi: 10.1007/s00296-020-04763-6. Epub 2021 Jan 2.

    172. Suri JS, Agarwal S, Gupta SK, Puvvula A, Biswas M, Saba L, Bit A, Tandel GS, Agarwal M, Patrick A, Faa G, Singh IM, Oberleitner R, Turk M, Chadha PS, Johri AM, Miguel Sanches J, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Ahluwalia P, Teji J, Al-Maini M, Dhanjil SK, Sockalingam M, Saxena A, Nicolaides A, Sharma A, Rathore V, Ajuluchukwu JNA, Fatemi M, Alizad A, Viswanathan V, Krishnan PK, Naidu S. A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. ComputBiol Med. 2021 Mar;130:104210. doi: 10.1016/j.compbiomed.2021.104210. Epub 2021 Jan 18.

    173. Misra DP *, Zimba O, Gasparyan AY. Statistical data presentation: a primer for rheumatology researchers. Rheumatol Int. 2021 Jan;41(1):43-55. doi: 10.1007/s00296-020-04740-z.

    174. Gupta L, Kharbanda R, Agarwal V, Misra DP, Agarwal V. Patient Perspectives on the Effect of the SARS-CoV-2 Pandemic on Patients With Systemic Sclerosis: An International Patient Survey. J Clin Rheumatol. 2021 Jan 1;27(1):31-33.

    175. Suri JS, Puvvula A, Majhail M, Biswas M, Jamthikar AD, Saba L, Faa G, Singh IM, Oberleitner R, Turk M, Srivastava S, Chadha PS, Suri HS, Johri AM, Nambi V, Sanches JM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Bit A, Pareek G, Miner M, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Kolluri R, Teji J, Porcu M, Al-Maini M, Agbakoba A, Sockalingam M, Sexena A, Nicolaides A, Sharma A, Rathore V, Viswanathan V, Naidu S, Bhatt DL. Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence. Rev Cardiovasc Med. 2020 Dec 30;21(4):541-560.

    176. Misra DP, Ravindran V. Authors* reply. J R Coll Physicians Edinb. 2020 Dec;50(4):456-461. doi: 10.4997/JRCPE.2020.428.

    177. Misra DP, Ravindran V. Revisions, Rejections and Rebuttals: The show must go on!. J R Coll Physicians Edinb. 2020 Dec;50(4):362-364.

    178. Patro P, Misra DP *. Registering and reporting systematic reviews. Cent Asian J Med Hypotheses Ethics 2020;1(2):122-126. https://doi.org/10.47316/cajmhe.2020.1.2.03

    179. Rathore U, Patro P, Agarwal V, Sharma A, Misra DP *. Disease-modifying antirheumatic drugs for the management of takayasu arteritis - Protocol for a systematic review. Indian J Rheumatol 2021;16:79-82

    180. Gupta L, Sharma S, Kharbanda R, Aggarwal S, Misra DP, Agarwal V. Virtual consulting in the times of COVID-19. Indian J Rheumatol 2021 [Epub ahead of print]

    181. Misra DP, Ravindran V. Citations analysis of publications. J R Coll Physicians Edinb 2021; 51: 11-2

    182. Misra DP *, Agarwal V. Present-day tools for assessing publishing integrity in biomedical science represent valuable work in progress. Clin Rheumatol. 2021 40(5):2111-2112. doi: 10.1007/s10067-021-05702-x.

    183. Naveen R, Verma A, Raza HA, Chengappa KG, R Naidu GS, Sharma S, Goel A, Misra DP, Sharma A, Gupta L, Agarwal V. Prescription practices, experiences, and perspectives on the usage of hydroxychloroquine among rheumatologists and other specialists. Indian J Rheumatol 2021;16:169-78

    184. Misra DP *. Leptin and Lupus..........the Story Continues!. Indian J Rheumatol 2021;16:1-2.

    185. Viswanathan V, Puvvula A, Jamthikar AD, Saba L, Johri AM, Kotsis V, Khanna NN, Dhanjil SK, Majhail M, Misra DP, Agarwal V, Kitas GD, Sharma AM, Kolluri R, Naidu S, Suri JS. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J Diabetes 2021; 12(3): 215-237

    186. Misra DP *. My life as a researcher and editor. Cent Asian J Med Hypotheses Ethics 2021;2(1):62-65.

    187. Mehta P, Gupta L, Muhammed H, Misra DP, Lawrence A, Agarwal V, Aggarwal A, Misra R. Spectrum of Myelitis in Systemic Lupus Erythematosus: Experience from a Single Tertiary Care Center over 25 Years. Mediterr J Rheumatol 2021;32(1):31-38.

    188. Hazarika K, Sahoo RR, Mohindra N, Wakhlu A, Manoj M, Bafna P, Garg R, Misra DP, Agarwal V, Wakhlu A. Clinical, radiologic and serologic profile of patients with interstitial pneumonia with autoimmune features: a cross-sectional study Rheumatol Int 2021 May 27;1-11. [Online ahead of print]

    189. Misra DP*, Rathore U, Patro P, Agarwal V, Sharma A. Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis. Clin Rheumatol. 2021 May 1;1-26. doi: 10.1007/s10067-021-05743-2. Online ahead of print.

    190. Misra DP*, Thomas KN, Gasparyan AY, Zimba O. Mechanisms of thrombosis in ANCA-associated vasculitis. Clin Rheumatol. 2021 Jun 9:1-9. doi: 10.1007/s10067-021-05790-9. Online ahead of print.

    191. Misra DP, Ravindran V. Detecting and handling suspected plagiarism in submitted manuscripts. J R Coll Physicians Edinb. 2021 Jun;51(2):115-117. doi: 10.4997/JRCPE.2021.201.

    192. Rollefstad S, Ikdahl E, Wibetoe G, Sexton J, Crowson CS, van Riel P, Kitas GD, Graham I, Dahlqvist SR, Karpouzas G, Myasoedova E, Gonzalez-Gay MA, Sfikakis PP, Tektonidou MG, Lazarini A, Vassilopoulos D, Kuriya B, Hitchon CA, Stoenoiu MS, Durez P, Pascual-Ramos V, Galarza-Delgado DA, Faggiano P, Misra DP, Borg A, Mu R, Mirrakhimov EM, Gheta D, Myasoedova S, Krougly L, Popkova T, Tuchynová A, Tomcik M, Vrablik M, Lastuvka J, Horák P, Medková H, Semb AG. An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis-results from 19 countries. Eur Heart J Cardiovasc Pharmacother. 2021 Jul 7:pvab052. doi: 10.1093/ehjcvp/pvab052. Epub ahead of print.

    193. Biswas M, Saba L, Omerzu T, Johri AM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Balestrieri A, Sfikakis PP, Protogerou A, Misra DP, Agarwal V, Kitas GD, Kolluri R, Sharma A, Viswanathan V, Ruzsa Z, Nicolaides A, Suri JS. A Review on Joint Carotid Intima-Media Thickness and Plaque Area Measurement in Ultrasound for Cardiovascular/Stroke Risk Monitoring: Artificial Intelligence Framework. J Digit Imaging. 2021 Jun 2;. doi: 10.1007/s10278-021-00461-2. [Epub ahead of print]

    194. Misra DP *. Autoimmune myelofibrosis associated with lupus: unusual or undetected? Cent Asian J Med Hypotheses Ethics 2021:2(2):101-103. https://doi.org/10.47316/cajmhe.2021.2.2.XX

    195. Muhammed H, Jain A, Pattanaik SS, Chatterjee R, Naveen R, Kabeer H, Gupta L, Misra DP, Agarwal V, Lawrence A, Misra R, Aggarwal A. Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus. Rheumatol Int. 2021 Jun 30. doi: 10.1007/s00296-021-04933-0. Online ahead of print.

    196. Semb AG, Rollefstad S, Ikdahl E, Wibetoe G, Sexton J, Crowson C, van Riel P, Kitas G, Graham I, Rantapää-Dahlqvist S, Karpouzas GA, Myasoedova E, Gonzalez-Gay MA, Sfikakis PP, Tektonidou MGG, Lazarini A, Vassilopoulos D, Kuriya B, Hitchon C, Stoenoiu MS, Durez P, Pascual-Ramos V, Galarza-Delgado DA, Faggiano P, Misra DP, Borg AA, Mu R, Mirrakhimov EM, Gheta D, Douglas K, Agarwal V, Myasoedova S, Krougly L, ValentinovnaPopkova T, Tuchynová A, Tomcik M, Vrablik M, Lastuvka J, Horak P, Medkova HK, Kerola AM; SURF-RA collaborators. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit. RMD Open. 2021 Jul;7(2):e001724. doi: 10.1136/rmdopen-2021-001724.

    197. Saba L, Sanagala S, Gupta S, Koppula V, Johri A, Khanna N, Mavrogeni S, Laird J, Pareek G, Miner M, kakis P, Protogerou A, Misra D, Agarwal V, Sharma A, Viswanathan V, Rathore V, Turk M, Kolluri R, Viskovic K, Cuadrado-Godia E, Kitas G, Sharma N, Nicolaides A, Suri J. (2021). Multimodality carotid plaque tissue characterization and classification in the artificial intelligence paradigm: a narrative review for stroke application. Ann Transl Med 2021 Online ahead of print. doi:10.21037/atm-20-7676

    198. Gupta L, Aggarwal R, Naveen R, Lawrence A, Zanwar A, Misra DP, Agarwal V, Misra R, Aggarwal A. High Prevalence of Active Tuberculosis in Adults and Children with Idiopathic Inflammatory Myositis as Compared with Systemic Lupus Erythematosus in a Tuberculosis Endemic Country: Retrospective Data Review from a Tertiary Care Centre in India. Mediterr J Rheumatol 2020;32(2):134-42.

    199. Misra DP *, Rathore U, Patro P, Agarwal V, Sharma A. Corticosteroid monotherapy for the management of Takayasu arteritis - a systematic review and meta-analysis. Rheumatol Int 2021 Jul 23. doi: 10.1007/s00296-021-04958-5. Online ahead of print.

    200. Misra DP, Ravindran V. Systematic reviews: current perspectives and future directions. J R Coll Physicians Edinb. 2021; 51: 218-20.

    201. Misra DP *, Rathore U, Patro P, Agarwal V, Sharma A. Patient-Reported Outcome Measures in Takayasu Arteritis - a Systematic Review and Meta-Analysis. RheumatolTher 2021 doi:10.1007/s40744-021-00355-3

    202. Suri JS, Agarwal S, Pathak R, Ketireddy V, Columbu M, Saba L, Gupta SK, Faa G, Singh IM, Turk M, Chadha PS, Johri AM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Teji JS, Al-Maini M, Dhanjil SK, Nicolaides A, Sharma A, Rathore V, Fatemi M, Alizad A, Krishnan PR, Frence N, Ruzsa Z, Gupta A, Naidu S, Kalra M. COVLIAS 1.0: Lung Segmentation in COVID-19 Computed Tomography Scans Using Hybrid Deep Learning Artificial Intelligence Models. Diagnostics. 2021; 11(8):1405. https://doi.org/10.3390/diagnostics11081405

    203. Campochiaro C, Misra DP *. PET in Takayasu arteritis: onwards and upwards towards a future of robust multimodality disease activity assessment? Rheumatology (Oxford) 2021 Aug 9;keab644. doi: 10.1093/rheumatology/keab644. Online ahead of print.

    204. Gupta L, Khan H, Sinha M, Misra DP *, Kharbanda R, Chatterjee T, Nune A, Agarwal V. Rheumatology education in India: a survey-based cross sectional study. Rheumatol Int. 2021 Aug 6:1-11. doi: 10.1007/s00296-021-04962-9. Epub ahead of print.

    205. Gupta L, Tariq J, Yessirkepov M, Zimba O, Misra DP, Agarwal V, Gasparyan AY. Plagiarism in Non-Anglophone Countries: a Cross-sectional Survey of Researchers and Journal Editors. J Korean Med Sci. 2021;36(39):e247. https://doi.org/10.3346/jkms.2021.36.e247

    206. Kopp CR, Naidu G, Misra DP, Deo P, Jakulla RS, Makan K, Maharaj A, Agarwal V, Sharma A. Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey. Rheumatol Int. 2021 Aug 24;.doi: 10.1007/s00296-021-04975-4. [Epub ahead of print] PubMed PMID: 34427760.

    207. Misra DP *, Agarwal V, Gasparyan AY, Zimba O, Sharma A. Highly cited papers in Takayasu arteritis on Web of Science and Scopus: cross-sectional analysis. Clin Rheumatol 2021 Sep 4. doi: 10.1007/s10067-021-05901-6. Online ahead of print.

    208. Thomas KN, Jain N, Mohindra N, Misra DP, Agarwal V, Gupta L. MRI and Sonography of the Knee in Acute Reactive Arthritis: An Observational Cohort Study. J Clin Rheumatol. 2021 Sep 17. doi: 10.1097/RHU.0000000000001785. Epub ahead of print.

    209. Pandey G, Singh H, Chaturvedi S, Hatti M, Kumar A, Mishra A, Mishra P, Krishna VP, Bhadauria A, Mohindra S, Misra DP, Saraswat VA, Agarwal V. Utility of neutrophil CD64 in distinguishing bacterial infection from inflammation in severe alcoholic hepatitis fulfilling SIRS criteria. Sci Rep 2021; 11: 19726. https://doi.org/10.1038/s41598-021-99276-y

    210. Rathore U, Thakre DR, Patro P, Agarwal V, Sharma A, Misra DP*. A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis. Clin Rheumatol 2021 [Accepted]

    211. Suri JS, Agarwal S, Elavarthi P, Pathak R, Ketireddy V, Columbu M, Saba L, Gupta SK, Faa G, Singh IM, Turk M, Chadha PS, Johri AM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Teji JS, Al-Maini M, Dhanjil SK, Nicolaides A, Sharma A, Rathore V, Fatemi M, Alizad A, Krishnan PR, Ferenc N, Ruzsa Z, Gupta A, Naidu S, Kalra MK. Inter-Variability Study of COVLIAS 1.0: Hybrid Deep Learning Models for COVID-19 Lung Segmentation in Computed Tomography. Diagnostics. 2021; 11(11):2025. https://doi.org/10.3390/diagnostics11112025

    212. Misra DP, Gasparyan AY, Zimba O, Yessirkepov M, Agarwal V, Kitas GD. Formulating hypotheses for different study designs. J Korean Med Sci. 2021 Dec 27;36(50):e338 [Accepted]

    213. Misra DP, Ravindran V. Preprint publications: waste in haste or pragmatic progress? J R Coll Physicians Edinb. 2021 Dec;51(4):324-326. doi: 10.4997/JRCPE.2021.401.

    214. Gupta L, Naveen R, Ahmed S, Zanwar A, Misra DP, Lawrence A, Agarwal V, Misra R, Aggarwal A. Juvenile Reactive Arthritis and other Spondyloarthritides of Childhood: A 28-year Experience from India. Mediterr J Rheumatol 2021;32(4):338-44.

    215. Suri JS, Agarwal S, Carriero A, Paschč A, Danna PSC, Columbu M, Saba L, Viskovic K, Mehmedovic A, Agarwal S, Gupta L, Faa G, Singh IM, Turk M, Chadha PS, Johri AM, Khanna NN, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Teji JS, Al-Maini M, Dhanjil SK, Nicolaides A, Sharma A, Rathore V, Fatemi M, Alizad A, Krishnan PR, Nagy F, Ruzsa Z, Gupta A, Naidu S, Paraskevas KI, Kalra MK. COVLIAS 1.0 vs. MedSeg: Artificial Intelligence-Based Comparative Study for Automated COVID-19 Computed Tomography Lung Segmentation in Italian and Croatian Cohorts. Diagnostics (Basel). 2021 Dec 15;11(12). doi: 10.3390/diagnostics11122367.

    216. Munjral S, Ahluwalia P, Jamthikar AD, Puvvula A, Saba L, Faa G, Singh IM, Chadha PS, Turk M, Johri AM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Kolluri R, Teji J, Al-Maini M, Dhanjil SK, Sockalingam M, Saxena A, Sharma A, Rathore V, Fatemi M, Alizad A, Viswanathan V, Krishnan PK, Omerzu T, Naidu S, Nicolaides A, Suri JS. Nutrition, atherosclerosis, arterial imaging, cardiovascular risk stratification, and manifestations in COVID-19 framework: a narrative review. Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1312-1339. doi: 10.52586/5026.

    * Corresponding author

    Textbook Chapters Published:

    1. Misra DP, Wakhlu A, Agarwal V. Pathogenesis of vasculitis. In Sharma A (Ed), Textbook of Systemic Vasculitis. 1st Ed. Jaypee Brothers Medical Publishers (P) Ltd. 2015. pp 40-48.

    2. Misra DP *, Negi VS. Adult-onset Still*s disease in Chaturvedi V [Ed] Manual of Rheumatology 5th Ed. CBS Publishers and Distributors Pvt. Ltd. 2017. pp 622-630

    3. Misra DP *, Ajmani S, Agarwal V. Lyme arthritis. In. Handa R, Sharma A [Ed.] Tropical Rheumatology, 1st Edition. Indian College of Physicians 2018. pp 33-41

    4. Gupta L, Wakhlu A, Misra DP, Agarwal V. Arthritis in leprosy. In. Handa R, Sharma A [Ed.] Tropical Rheumatology, 1st Edition. Indian College of Physicians 2018. pp 24-32

    5. Handa R, Sharma A, Misra DP. Section 9: Rheumatology and Immunology. In. Yearbook of Medicine 2018. Jaypee Publishers 2018. pp 258-285

    6. Patro P, Misra DP *, Agarwal V. Management of PsA-conventional drugs. In Sharma A, Handa R (Ed). Rheumatology Clinics-Psoriasis and Psoriatic Arthritis. 2020 Ed. Evangel Publishing House

    7. Misra DP *, Agarwal V. Amyloidosis. In Santhanam S, Ravindran V [Ed.]. ICP monogram on Rheumatic Rarities 2018. Evangel Publishing House pp. 10-17

    8. Handa R, Sharma A, Misra DP. Section 9: Rheumatology and Immunology. In. Yearbook of Medicine 2019. Jaypee Publishers 2019. pp 273-306.

    9. Chowdhury AC, Misra DP. Emerging therapeutics in Osteoarthritis. In Ravindran V [Ed]. Handbook of Rheumatic Diseases - Osteoarthritis. Evangel Publishing House 2020 pp132-140

    10. Sahoo RR, Misra DP, Wakhlu. Biologic Therapy in Psoriatic arthritis. In Handa R, Sharma A (Ed).Rheumatology Clinics - Psoriasis and Psoriatic Arthritis 2020 1st ed. Evangel Publishing House. Pp 106-114.

    11. Misra DP *, Patro P, Agarwal V. Biosimilars: Bane or boon for India. In Tewary K K Ed. Medicine Update 2021 ed. Evangel Publishing House. pp 1347-1352 [Accepted]

    12. Mehta PK, Misra DP *, Agarwal V. Pathogenesis of Ankylosing Spondylitis. In Handa R, Sharma A (Ed). Rheumatology Clinics-Spondyloarthritides. 2021 ed Evangel Publishing House. Pp 155-161

    13. Handa R, Sharma A, Misra DP. Section 9: Rheumatology and Immunology. In. Yearbook of Medicine 2020. Jaypee Publishers 2020. Pp 311-343

    14. Kharbanda R, Agarwal V, Misra DP. Systemic Sclerosis. In Handa R, Sharma A (Ed).Urgencies and Emergencies in Rheumatology 2021 2nd ed. Evangel Publishing House. Pp 29-41

    15. Misra DP *, Patro P, Agarwal V. Systemic Reviews: Methodology and Relevance for the Internist. In Sundar S (Ed.) Medicine Update 2022 ed. Evangel Publishing House.

    * Corresponding author